Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00779857 · ClinicalTrials.gov registry record · Phase 2
AtriCure Exclusion of the LAA in Patients Undergoing Concomitant Cardiac Surgery
A Phase 2 study, sponsored by AtriCure.
- Completed
- Registry status
- Phase 2
- Development phase
- 70
- Enrollment target
NCT00779857: Completed Phase 2 study, sponsored by AtriCure.
NCT00779857 is a Phase 2 study that has completed, run by AtriCure. The registered enrollment target is 70 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00779857, a Phase 2 study, has completed, sponsored by AtriCure.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 70 participants
- Enrollment target
Study Summary
Prospective, non-randomized trial to evaluate the safety and efficacy of the LAA Exclusion Device (Clip) for the exclusion of the LAA via epicardial tissue approximation.
Primary Outcome
The primary safety endpoint is the rate of device related serious adverse events within 30 days post-procedure or hospital discharge, whichever is later, compared with the rates for serious adverse events for LAA exclusion reported in the peer review literature. The safety endpoint was determined based on an independent review of all reported adverse events by an independent cardiac surgeon that was not an investigator in the study.
Interventions
- DEVICE AtriCure LAA Exclusion System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2008-09 |
| Est. Completion | 2011-10 |
| Phase | Phase 2 |
What the finished NCT00779857 record still lists
NCT00779857 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 1 intervention - of which AtriCure LAA Exclusion System is the first listed.
NCT00779857 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00779857 about?
NCT00779857 is a clinical study titled "AtriCure Exclusion of the LAA in Patients Undergoing Concomitant Cardiac Surgery". Prospective, non-randomized trial to evaluate the safety and efficacy of the LAA Exclusion Device (Clip) for the exclusion of the LAA via epicardial tissue approximation.
What is the current status of trial NCT00779857?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 70 participants. The study started on 2008-09. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00779857?
The interventions under investigation include: AtriCure LAA Exclusion System (DEVICE).
Who is sponsoring clinical trial NCT00779857?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00779857's enrollment target sits among peer trials
70 937th of 2000 higher than 1,036 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia